<DOC>
	<DOCNO>NCT00003903</DOCNO>
	<brief_summary>RATIONALE : Assessing effect androgen suppression bone loss prostate cancer patient may improve ability plan treatment , may decrease risk fracture bony pain , may help patient live comfortably . PURPOSE : Clinical trial determine effect androgen suppression bone loss patient prostate cancer .</brief_summary>
	<brief_title>Effect Androgen Suppression Bone Loss Patients With Without Bone Metastases Secondary Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate effect androgen ablation bone resorption patient without bone metastasis secondary prostate cancer . OUTLINE : Patients stratify accord prior androgen ablation therapy ( yes v ) metastatic disease ( yes v ) . Patients undergo blood work 24 hour urine collection day 1 week 6-8 . Patients receive androgen ablation therapy find increase bone resorption undergo dual energy x-ray absorptiometry ( DEXA ) scan . A comparison make androgen ablation therapy bone resorption metastasis associate two . PROJECTED ACCRUAL : A total 150 patient accrue study within 9 month .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm prostate cancer Stratum 1 ( androgen ablation therapy ) : Bone metastases Prior orchiectomy allow Prior concurrent leuprolide and/or goserelin therapy allow Stratum 2 ( androgen ablation therapy ) : No bone metastases Prior orchiectomy allow Prior concurrent leuprolide and/or goserelin therapy allow Stratum 3 ( androgen ablation therapy ) : No metastatic disease Prior flutamide bicalutamide therapy allow PATIENT CHARACTERISTICS : Age : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Calcium normal Hepatic : Not specify Renal : Not specify PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : See Disease Characteristics Endocrine therapy : See Disease Characteristics No concurrent high dose steroid Radiotherapy : Prior radiotherapy allow Surgery : See Disease Characteristics Prior radical prostatectomy allow Other : No concurrent bisphosphonates</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>osteoporosis</keyword>
</DOC>